Skip to main content

Table 5 Results obtained from the two methods

From: Comparison of methods for calculating the health costs of endocrine disrupters: a case study on triclosan

Adverse effect Number of cases
IPRA PAF
Decrease in vas deferens weight/adverse effect on testicular function 4894 --------
Increased T3 levels 0 88,957–303,759
Early pubertal development 0 281,923
Obesity -------- 7,199,228